Inventor
SHALWITZ ROBERT
US31 patents
⚠️ This page may combine multiple inventors who share the name “SHALWITZ ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AERPIO THERAPEUTICS INC
14 patentsUS10329357B2Jun 25, 2019
Treatment of ocular disease
AERPIO THERAPEUTICS INC16 citations94
US10220048B2Mar 5, 2019
Compositions and methods for treating ocular diseases
AERPIO THERAPEUTICS INC19 citations94
US9949956B2Apr 24, 2018
Compounds, compositions, and methods for preventing metastasis of cancer cells
AERPIO THERAPEUTICS INC21 citations94
US9174950B2Nov 3, 2015
Compounds, compositions, and methods for preventing metastasis of cancer cells
AERPIO THERAPEUTICS INC32 citations94
US9096555B2Aug 4, 2015
Methods for treating vascular leak syndrome
AERPIO THERAPEUTICS INC32 citations94
US8999325B2Apr 7, 2015
Treatment of ocular disease
AERPIO THERAPEUTICS INC36 citations94
US8883832B2Nov 11, 2014
Compounds, compositions, and methods for preventing metastasis of cancer cells
AERPIO THERAPEUTICS INC38 citations94
US9440963B2Sep 13, 2016
Compositions, formulations and methods for treating ocular diseases
AERPIO THERAPEUTICS INC35 citations93
US10150811B2Dec 11, 2018
Methods for treating vascular leak syndrome and cancer
AERPIO THERAPEUTICS INC15 citations92
US9278930B2Mar 8, 2016
Methods for increasing the stabilization of hypoxia inducible factor-α
AERPIO THERAPEUTICS INC8 citations92
US8999971B2Apr 7, 2015
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
AERPIO THERAPEUTICS INC10 citations92
US8883774B2Nov 11, 2014
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
AERPIO THERAPEUTICS INC12 citations92
US9540326B2Jan 10, 2017
Prolyl hydroxylase inhibitors
AERPIO THERAPEUTICS INC5 citations84
US10562854B2Feb 18, 2020
Prolyl hydroxylase inhibitors
AERPIO THERAPEUTICS INC0 citations52
INVIRSA INC
6 patentsUS11110112B2Sep 7, 2021
Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
INVIRSA INC4 citations83
US10946034B2Mar 16, 2021
Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
INVIRSA INC5 citations83
US11857561B2Jan 2, 2024
Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
INVIRSA INC2 citations72
US12233083B2Feb 25, 2025
Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
INVIRSA INC1 citations69
US11793826B2Oct 24, 2023
Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
INVIRSA INC2 citations67
US12370209B2Jul 29, 2025
Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
INVIRSA INC0 citations62
GARDNER JOSEPH H
3 patentsSHALWITZ ROBERT
3 patentsUS8865748B2Oct 21, 2014
Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
SHALWITZ ROBERT28 citations91
US8778412B2Jul 15, 2014
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
SHALWITZ ROBERT10 citations91
US8569348B2Oct 29, 2013
Compounds, compositions, and methods for preventing metastasis of cancer cells
SHALWITZ ROBERT37 citations88